Screening for substance abuse and diversion in virginia hospices

Journal of Palliative Medicine

Volumn 16, Issue 3, 2013, Pages 237-242

  Blackhall, Leslie J ^a   Alfson, Elizabeth D ^b   Barclay, Joshua S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DRUG SCREENING; FAMILY HISTORY; HEALTH CARE POLICY; HOSPICE CARE; HUMAN; MULTICENTER STUDY; OPIATE ADDICTION; PERCEPTION; POLICY; STAFF TRAINING; SUBSTANCE ABUSE; UNITED STATES;

ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FAMILY; FEMALE; HOSPICES; HUMANS; INSERVICE TRAINING; MALE; ORGANIZATIONAL POLICY; PAIN; RISK FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; VIRGINIA;

EID: 84874471074     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0263     Document Type: Article

References (39)

1. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.
2. Jacox A CD, Payne R, et al. Management of Cancer Pain. Clinical Practice Guideline. Vol. 9. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, 1994.
3. Kuehn BM: Opioid prescriptions soar: Increase in legitimate use as well as abuse. JAMA 2007;297:249-251.
4. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C: Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009;18:1166-1175.
5. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-742.
6. Organization NHaPC: NHPCO Facts and Figures: Hospice Care in America. 2011. www.nhpco.org/files/public/statistics- research/2011-facts-figures.pdf (Last accessed April 19, 2012).
7. Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW: Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J 2010;160:139-144.
8. Portenoy RK, Sibirceva U, Smout R, Horn S, Connor S, Blum RH, Spence C, Fine PG: Opioid use and survival at the end of life: A survey of a hospice population. J Pain Symptom Manage 2006;32:532-540.
9. Jenkins CA, Schulz M, Hanson J, Bruera E: Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital. J Pain Symptom Manage 2000;19:174-184.
10. Okie S: A flood of opioids, a rising tide of deaths. N Engl J Med 2010;363:1981-1985.
11. Paulozzi LJ, Ryan GW: Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med 2006;31:506-511.
12. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-1321.
13. Wunsch MJ, Nakamoto K, Behonick G, Massello W: Opioid deaths in rural Virginia: A description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict 2009;18:5-14.
14. Substance Abuse and Mental Health Services Administration: Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011.
15. Parsons HA, Delgado-Guay MO, El Osta B, Chacko R, Poulter V, Palmer JL, Bruera E: Alcoholism screening in patients with advanced cancer: Impact on symptom burden and opioid use. J Palliat Med 2008;11:964-968.
16. Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M: The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 1995;10:599-603.
17. Dev R, Parsons HA, Palla S, Palmer JL, Del Fabbro E, Bruera E: Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer 2011;117:4551-4556.
18. Childers JW, Arnold RM: ''I feel uncomfortable 'calling a patient out''': Educational needs of palliative medicine fellows in managing opioid misuse. J Pain Symptom Manage 2012;43:253-260.
19. Passik SD, Theobald DE: Managing addiction in advanced cancer patients: Why bother? J Pain Symptom Manage 2000;19:229-234.
20. Ballantyne JC: Opioid misuse in oncology pain patients. Curr Pain headache Rep 2007;11:276-282.
21. American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders, 4th ed. Washington, DC: APA, 1994.
22. Gonzales GR, Coyle N: Treatment of cancer pain in a former opioid abuser: Fears of the patient and staff and their influence on care. J Pain Symptom Manage 1992;7:246-249.
23. Chou R: 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: What are the key messages for clinical practice? Polskie Archiwum Medycyny Wewnetrznej 2009;119:469-477.
24. Fleming MF, Davis J, Passik SD: Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008;9:1098-1106.
25. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, Jamison RN: Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28:250-258.
26. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK: Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-146.
27. Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med 2005;6:432-442.
28. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN: Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J pain 2008;9:360-372.
29. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN: Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 2006;32:287-293.
30. Butler SF, Budman SH, Fernandez K, Jamison RN: Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65-75.
31. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ: Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med 2010;152:712-720.
32. Passik SD, Kirsh KL: Assessing aberrant drug-taking behaviors in the patient with chronic pain. Curr Pain Headache Rep 2004;8:289-294.
33. Worley J: Prescription drug monitoring programs, a response to doctor shopping: Purpose, effectiveness, and directions for future research. Issues Ment Health Nurs 2012;33:319-328.
34. Gugelmann HM, Perrone J: Can prescription drug monitoring programs help limit opioid abuse? JAMA 2011;306:2258-2259.
35. Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, Dart RC, Bucher Bartelson B: Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med 2012;13:434-442.
36. Kirsh KL, Passik SD: Palliative care of the terminally ill drug addict. Cancer Invest 2006;24:425-431.
37. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-130.
38. Amodeo M: The therapeutic attitudes and behavior of social work clinicians with and without substance abuse training. Subst Use Misuse 2000;35:1507-1536.
39. Virginia Association for Hospice and Palliative Care Risk Evaluation & Mitigation Tool-Kit: Strategies to Promote the Safe Use of Opioids. Information at info@virginiahospices.org.